New antibiotics need new partnerships
This article was originally published in Scrip
Executive Summary
Infections are fast becoming the new neglected diseases. As antibiotics lose their effectiveness against serious bacterial illnesses because of the rise in resistant pathogens, the likelihood is growing that common treatable conditions such as pneumonia and tuberculosis will again become fatal diseases – and not just in developing countries.